In type 2 diabetic rat animal models, Gastrodia significantly improved hypothalamic insulin signaling, enhanced insulin sensitivity, and reduced hepatic glycogen output in a hyper insulinemic state [95]. The gene discussed is INS; the disease is type 2 diabetes mellitus.